<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="IHEP - Integrated Health Empowerment Program: AI-powered comprehensive healthcare platform for HIV/AIDS care with NIST AI RMF 1.0 compliance and Zero Trust security architecture.">
    <title>IHEP Framework | Integrated Health Empowerment Program - Jason Jarmacz</title>
    <link rel="stylesheet" href="styles/main.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <link rel="stylesheet" href="styles/utilities.css">
    <link rel="stylesheet" href="styles/ihep.css">
</head>
<body>
    <!-- Navigation -->
    <nav class="main-nav" id="mainNav">
        <div class="nav-container">
            <div class="logo">
                <a href="index.html" aria-label="Jason Jarmacz home">
                    <img src="images/1000002043.jpg" alt="Jason Jarmacz logo" class="site-logo">
                    <span class="logo-text">JARMACZ</span>
                </a>
            </div>
            <ul class="nav-menu" id="navMenu">
                <li><a href="index.html#innovations">Portfolio</a></li>
                <li><a href="frameworks.html">Frameworks</a></li>
                <li><a href="projects_portfolio.html">Projects</a></li>
                <li><a href="services.html">Services</a></li>
                <li><a href="index.html#contact">Contact</a></li>
            </ul>
            <div class="nav-toggle" id="navToggle">
                <span></span>
                <span></span>
                <span></span>
            </div>
        </div>
    </nav>

    <!-- Hero Section -->
    <section class="hero u-min-pad-120px-pad-60px">
        <div class="container">
            <div class="u-tex-center-max-mar-0-auto">
                <div class="paper-tag u-dis-inline-mar-20px">Healthcare AI / NIST AI RMF 1.0 Compliant</div>
                <h1 class="u-fon-3-5rem-col-neutral-mar-25px-lin">
                    IHEP: Integrated Health Empowerment Program
                </h1>
                <p class="u-fon-1-4rem-col-accent-c-mar-30px-lin">
                    AI-powered comprehensive healthcare platform for HIV/AIDS care with Zero Trust security, patient digital twins, and 10-year roadmap to functional cure
                </p>
                <div class="u-dis-flex-gap-jus-fle-mar-40px">
                    <div>
                        <div class="u-fon-2-5rem-fon-bold-col-primary-">350-5K</div>
                        <div class="contact-item a">Patient Capacity (Scalable)</div>
                    </div>
                    <div>
                        <div class="u-fon-2-5rem-fon-bold-col-primary-">≥95%</div>
                        <div class="contact-item a">Viral Suppression Target</div>
                    </div>
                    <div>
                        <div class="u-fon-2-5rem-fon-bold-col-primary-">35%</div>
                        <div class="contact-item a">Care Cost Reduction</div>
                    </div>
                    <div>
                        <div class="u-fon-2-5rem-fon-bold-col-primary-">100%</div>
                        <div class="contact-item a">NIST AI RMF Compliant</div>
                    </div>
                </div>
                <div class="cta-group">
                    <a class="btn btn-primary" href="docs/IHEP_Executive_Summary.pdf" download>Download IHEP Executive Summary</a>
                </div>
            </div>
        </div>
    </section>

    <!-- Table of Contents -->
    <section class="u-pad-40px-0-bac-rgba-0-0">
        <div class="container">
            <h2 class="u-col-neutral-mar-20px-tex-center">Framework Documentation Index</h2>
            <div class="u-dis-grid-gri-gap-max-mar-0-auto">
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#executive-summary">Executive Summary</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#nist-compliance">NIST Compliance Architecture</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#digital-twin">Patient Digital Twin</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#generative-bioai">Generative Bio-AI</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#community-integration">Community Integration</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#funding-roadmap">Funding Roadmap</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#cure-milestones">10-Year Cure Roadmap</a>
                <a class="u-pad-12px-2-bac-rgba-0-2-bor-1px-soli-bor-col-n" href="#technical-architecture">Technical Architecture</a>
            </div>
        </div>
    </section>

    <!-- Executive Summary -->
    <section class="u-pad-80px-0 frameworks" id="executive-summary" >
        <div class="container">
            <div class="framework-item">
                <h2 class="u-fon-2-5rem-col-neutral-mar-30px"><i class="fas fa-clipboard-list"></i> Executive Summary</h2>

                <p class="u-col-neutral-fon-1-1rem-lin-mar-25px">
                    The Integrated Health Empowerment Program (IHEP) is a comprehensive AI-powered healthcare platform targeting HIV/AIDS care with a dual mission:
                </p>

                <div class="u-dis-grid-gri-gap-mar-30px-0">
                    <div class="u-bac-rgba-0-2-bor-pad-25px-bor">
                        <h3 class="u-col-primary-mar-15px"><i class="fas fa-heartbeat"></i> Near-Term Mission (Years 0-3)</h3>
                        <p class="u-col-neutral-lin">
                            Optimize existing HIV care through <strong>Patient Digital Twins</strong>, predictive analytics, and community-integrated support systems. Target: <strong>≥95% viral suppression</strong> (vs 87% national average) with <strong>35% cost reduction</strong> per patient annually.
                        </p>
                    </div>
                    <div class="u-bac-rgba-123-bor-pad-25px-bor">
                        <h3 class="u-col-primary-mar-15px-2"><i class="fas fa-flask"></i> Long-Term Vision (Years 4-10)</h3>
                        <p class="u-col-neutral-lin">
                            Leverage accumulated patient data and <strong>Generative Bio-AI</strong> to discover novel therapeutic agents targeting HIV latency. Goal: <strong>Functional cure</strong> (undetectable viral load without antiretroviral therapy) for at least 30% of patients by Year 10.
                        </p>
                    </div>
                </div>

                <div class="u-bac-rgba-255-bor-2px-soli-pad-30px-bor-mar-40p">
                    <h3 class="u-col-accent-m-mar-20px"><i class="fas fa-shield-alt"></i> IHEP's Unique Value Proposition</h3>
                    <ul class="card-features u-fon-1-05re">
                        <li><strong>NIST AI RMF 1.0 Compliance:</strong> First HIV care platform with full NIST AI Risk Management Framework adherence, enabling federal contracts and reducing regulatory risk</li>
                        <li><strong>Zero Trust Architecture:</strong> NIST SP 800-207 implementation ensures FBI CJIS-level security, critical for handling sensitive health records</li>
                        <li><strong>Recursive Learning Loop:</strong> Patient digital twins continuously update from clinical observations, creating ever-improving predictive models</li>
                        <li><strong>Dual Revenue Streams:</strong> Near-term care optimization (B2B SaaS to clinics) + long-term therapeutic IP (pharma licensing)</li>
                        <li><strong>Community-Centric Design:</strong> Peer navigator integration and culturally-tailored interventions drive engagement rates 40% higher than traditional clinic models</li>
                    </ul>
                </div>

                <!-- Multi-Stakeholder Value Proposition -->
                <h3 class="u-col-neutral-mar-50px-0"><i class="fas fa-users"></i> Multi-Stakeholder Value Proposition</h3>

                <div class="u-dis-grid-gri-gap-mar-40px">
                    <!-- C-Suite Translation -->
                    <div class="u-bac-rgba-0-2-bor-1px-soli-pad-25px-bor">
                        <h4 class="u-col-primary-mar-15px"><i class="fas fa-chart-line"></i> For C-Suite Executives</h4>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Market Opportunity:</strong> 1.2M people living with HIV in US, 5,000+ federally qualified health centers (FQHCs) addressable market. SaaS model: $500-2K per patient annually.
                        </p>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Risk Mitigation:</strong> NIST compliance reduces regulatory approval timeline by 6-12 months. Zero Trust architecture prevents data breaches (avg cost: $9.4M per incident in healthcare).
                        </p>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Exit Strategy:</strong> Acquisition by EHR vendors (Epic, Cerner) or healthcare AI platforms (Tempus, Flatiron) for $200M-500M by Year 5, or hold for therapeutic IP windfall.
                        </p>
                    </div>

                    <!-- Engineering Translation -->
                    <div class="u-bac-rgba-123-bor-1px-soli-pad-25px-bor">
                        <h4 class="u-col-primary-mar-15px-2"><i class="fas fa-code"></i> For Engineering Teams</h4>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Tech Stack:</strong> Python/Django backend, React frontend, PostgreSQL for structured data, MongoDB for unstructured clinical notes. TensorFlow/PyTorch for ML models.
                        </p>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Architecture:</strong> Microservices with Docker/Kubernetes deployment. Zero Trust network segmentation via Istio service mesh. FHIR/HL7 APIs for EHR interoperability.
                        </p>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Scalability:</strong> Target 350 patients at MVP, 5,000+ by Year 3. Horizontal scaling via AWS/GCP with multi-region failover. Sub-200ms API response times.
                        </p>
                    </div>

                    <!-- Operations Translation -->
                    <div class="u-bac-rgba-255-bor-1px-soli-pad-25px-bor">
                        <h4 class="u-col-accent-m-mar-15px"><i class="fas fa-cogs"></i> For Operations Teams</h4>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Clinical Workflow:</strong> Daily dashboard for care coordinators showing high-risk patients (predicted viral rebound, medication non-adherence). Automated SMS/email reminders for appointments.
                        </p>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Compliance:</strong> HIPAA BAA with all vendors, annual HITRUST certification, SOC 2 Type II audit trail. Automated audit logs for all data access (NIST SP 800-53r5 AU family).
                        </p>
                        <p class="u-col-neutral-mar-15px-fon-0-95re">
                            <strong>Training:</strong> 3-day clinician onboarding, online training portal, quarterly compliance refresher courses. 24/7 helpdesk with <4 hour response SLA.
                        </p>
                    </div>
                </div>

                <!-- Key Impact Metrics -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0">
                    <h4 class="u-col-neutral-mar-20px"><i class="fas fa-chart-bar"></i> Quantifiable Impact Metrics</h4>
                    <div class="u-dis-grid-gri-gap">
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">≥95%</div>
                            <div class="paper-date">Viral suppression rate (vs 87% national avg)</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">35%</div>
                            <div class="paper-date">Care cost reduction per patient annually</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">40%</div>
                            <div class="paper-date">Higher engagement vs traditional clinics</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">85%</div>
                            <div class="paper-date">Medication adherence rate (vs 65% baseline)</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">100%</div>
                            <div class="paper-date">NIST AI RMF + Zero Trust compliant</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">5,000+</div>
                            <div class="paper-date">Patient capacity by Year 3</div>
                        </div>
                    </div>
                </div>

            </div>
        </div>
    </section>

    <!-- NIST Compliance Architecture -->
    <section class="u-pad-80px-0-bac-linear-g frameworks" id="nist-compliance" >
        <div class="container">
            <div class="framework-item">
                <h2 class="u-fon-2-5rem-col-neutral-mar-30px"><i class="fas fa-lock"></i> NIST AI RMF 1.0 Compliance Architecture</h2>

                <p class="u-col-neutral-fon-1-1rem-lin-mar-40px">
                    IHEP is built on the NIST AI Risk Management Framework (AI RMF 1.0), a voluntary consensus standard for managing AI risks across governance, mapping, measurement, and management dimensions. This framework, combined with Zero Trust security (NIST SP 800-207), positions IHEP as the most secure and compliant HIV care AI platform available.
                </p>

                <!-- NIST AI RMF 1.0: Four Core Functions -->
                <div class="u-mar-60px">
                    <h3 class="u-col-primary-fon-2rem-mar-25px"><i class="fas fa-sitemap"></i> NIST AI RMF 1.0: Four Core Functions</h3>

                    <div class="u-dis-grid-gri-gap-2">
                        <!-- GOVERN -->
                        <div class="u-bac-rgba-0-2-bor-2px-soli-pad-25px-bor">
                            <h4 class="u-col-primary-mar-15px"><i class="fas fa-gavel"></i> 1. GOVERN</h4>
                            <p class="u-col-neutral-mar-15px-fon-0-95re">
                                <strong>Definition:</strong> Establish AI governance structure, policies, and oversight mechanisms
                            </p>
                            <p class="u-col-accent-c-fon-bold-mar-10px">IHEP Implementation:</p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li>AI Governance Board with clinical, technical, and ethics representatives</li>
                                <li>Documented AI risk appetite statement approved by executive leadership</li>
                                <li>Quarterly AI risk assessment reviews with board reporting</li>
                                <li>Clear accountability: Chief Medical Officer owns clinical safety, CTO owns technical security</li>
                                <li>Whistleblower policy for AI misuse or bias concerns</li>
                            </ul>
                        </div>

                        <!-- MAP -->
                        <div class="u-bac-rgba-123-bor-2px-soli-pad-25px-bor">
                            <h4 class="u-col-primary-mar-15px-2"><i class="fas fa-map-marked-alt"></i> 2. MAP</h4>
                            <p class="u-col-neutral-mar-15px-fon-0-95re">
                                <strong>Definition:</strong> Context identification, impact analysis, and risk categorization
                            </p>
                            <p class="u-col-accent-c-fon-bold-mar-10px">IHEP Implementation:</p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li><strong>Context:</strong> High-stakes medical decision support for HIV care (life-threatening if system fails)</li>
                                <li><strong>Impact Analysis:</strong> False negative (missing viral rebound) = patient harm; false positive = unnecessary treatment intensification</li>
                                <li><strong>Risk Categories:</strong> Clinical safety (highest), data privacy (high), algorithmic bias (high)</li>
                                <li>Sociotechnical impact mapping: How does AI affect clinician-patient relationship? Community trust?</li>
                            </ul>
                        </div>

                        <!-- MEASURE -->
                        <div class="u-bac-rgba-255-bor-2px-soli-pad-25px-bor">
                            <h4 class="u-col-accent-m-mar-15px"><i class="fas fa-ruler"></i> 3. MEASURE</h4>
                            <p class="u-col-neutral-mar-15px-fon-0-95re">
                                <strong>Definition:</strong> Track AI performance metrics, bias, and safety indicators
                            </p>
                            <p class="u-col-accent-c-fon-bold-mar-10px">IHEP Implementation:</p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li><strong>Performance:</strong> AUC-ROC ≥0.90 for viral rebound prediction, calibrated probability scores</li>
                                <li><strong>Bias Detection:</strong> Monthly fairness audits across race, gender, age, socioeconomic status (ensure no >5% performance gap)</li>
                                <li><strong>Safety Monitoring:</strong> Real-time anomaly detection for model drift, automatic rollback if accuracy drops >10%</li>
                                <li>Explainability: SHAP values for all predictions, clinician override rate tracked (target <5%)</li>
                            </ul>
                        </div>

                        <!-- MANAGE -->
                        <div class="u-bac-rgba-0-2-bor-2px-soli-pad-25px-bor-2">
                            <h4 class="u-col-accent-c-mar-15px"><i class="fas fa-tasks"></i> 4. MANAGE</h4>
                            <p class="u-col-neutral-mar-15px-fon-0-95re">
                                <strong>Definition:</strong> Incident response, continuous improvement, documentation
                            </p>
                            <p class="u-col-accent-c-fon-bold-mar-10px">IHEP Implementation:</p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li><strong>Incident Response:</strong> 24/7 on-call rotation for critical AI failures, <1 hour escalation SLA</li>
                                <li><strong>Root Cause Analysis:</strong> Post-incident review with corrective action plan (CAP) for all safety events</li>
                                <li><strong>Continuous Improvement:</strong> Quarterly model retraining with expanded datasets, A/B testing of algorithm updates</li>
                                <li>Documentation: Full audit trail in compliance with FDA 21 CFR Part 11 (electronic records/signatures)</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <!-- Additional NIST Standards -->
                <div class="u-mar-60px">
                    <h3 class="u-col-primary-fon-2rem-mar-25px"><i class="fas fa-shield-alt"></i> Comprehensive NIST Standards Alignment</h3>

                    <div class="u-bac-rgba-0-0-pad-30px-bor-mar-25px">
                        <h4 class="u-col-neutral-mar-20px">NIST SP 800-53r5: Security & Privacy Controls</h4>
                        <p class="u-col-neutral-mar-20px-2">
                            We implement a subset of the 1,000+ controls from NIST SP 800-53 Revision 5, focusing on high-impact controls for healthcare AI:
                        </p>
                        <div class="u-dis-grid-gri-gap-3">
                            <div>
                                <strong class="framework-content strong">AC (Access Control):</strong>
                                <span class="u-col-neutral-fon-0-9rem-dis-block-mar-5px">Role-based access control (RBAC), least privilege principle, MFA for all users</span>
                            </div>
                            <div>
                                <strong class="framework-content strong">AU (Audit & Accountability):</strong>
                                <span class="u-col-neutral-fon-0-9rem-dis-block-mar-5px">Comprehensive logging of all data access, immutable audit trails, 7-year retention</span>
                            </div>
                            <div>
                                <strong class="framework-content strong">SC (System & Communications Protection):</strong>
                                <span class="u-col-neutral-fon-0-9rem-dis-block-mar-5px">TLS 1.3 encryption in transit, AES-256 at rest, network segmentation</span>
                            </div>
                            <div>
                                <strong class="framework-content strong">SI (System & Information Integrity):</strong>
                                <span class="u-col-neutral-fon-0-9rem-dis-block-mar-5px">Input validation, flaw remediation, malware protection, intrusion detection</span>
                            </div>
                            <div>
                                <strong class="framework-content strong">IR (Incident Response):</strong>
                                <span class="u-col-neutral-fon-0-9rem-dis-block-mar-5px">Documented IR plan, annual tabletop exercises, breach notification procedures</span>
                            </div>
                            <div>
                                <strong class="framework-content strong">RA (Risk Assessment):</strong>
                                <span class="u-col-neutral-fon-0-9rem-dis-block-mar-5px">Annual risk assessments, vulnerability scanning (weekly), penetration testing (annual)</span>
                            </div>
                        </div>
                    </div>

                    <div class="u-bac-rgba-0-0-pad-30px-bor-mar-25px">
                        <h4 class="u-col-neutral-mar-20px">NIST SP 800-207: Zero Trust Architecture (ZTA)</h4>
                        <p class="u-col-neutral-mar-20px-2">
                            Zero Trust = "Never trust, always verify." Every access request is authenticated, authorized, and encrypted, regardless of network location.
                        </p>
                        <ul class="card-features">
                            <li><strong>Micro-segmentation:</strong> Each microservice runs in isolated network segment with strict firewall rules</li>
                            <li><strong>Continuous Authentication:</strong> Session tokens expire after 15 minutes, require re-authentication for sensitive operations</li>
                            <li><strong>Least Privilege:</strong> API endpoints scoped to minimal necessary permissions (e.g., care coordinators cannot access admin functions)</li>
                            <li><strong>Device Trust:</strong> Device posture checks (OS patching, antivirus status) before granting access</li>
                            <li><strong>Monitoring:</strong> Real-time anomaly detection for unusual access patterns (e.g., bulk data downloads)</li>
                        </ul>
                    </div>

                    <div class="u-bac-rgba-0-0-pad-30px-bor-mar-25px">
                        <h4 class="u-col-neutral-mar-20px">FBI CJIS Security Policy v5.9.1</h4>
                        <p class="u-col-neutral-mar-20px-2">
                            While IHEP doesn't handle criminal justice data, we adopt <strong>CJIS-level security</strong> to demonstrate the highest standard of data protection (many HIV patients have justice system involvement due to stigma/discrimination history).
                        </p>
                        <ul class="card-features">
                            <li><strong>Advanced Authentication:</strong> Multi-factor authentication (MFA) mandatory for all users, biometric options available</li>
                            <li><strong>Personnel Security:</strong> FBI fingerprint background checks for all staff with system access</li>
                            <li><strong>Physical Security:</strong> Data centers with biometric access controls, 24/7 video surveillance, annual audits</li>
                            <li><strong>Mobile Device Security:</strong> MDM (Mobile Device Management) with remote wipe capability, encrypted storage</li>
                        </ul>
                    </div>

                    <div class="u-bac-rgba-0-0-pad-30px-bor">
                        <h4 class="u-col-neutral-mar-20px">NISTIR 8259A: IoT Device Security</h4>
                        <p class="u-col-neutral-mar-20px-2">
                            IHEP integrates with IoT devices for patient monitoring (e.g., smart pill bottles for medication adherence, wearables for vitals). NISTIR 8259A provides device security baselines:
                        </p>
                        <ul class="card-features">
                            <li><strong>Device Identification:</strong> Unique cryptographic identity for each device, certificate-based authentication</li>
                            <li><strong>Secure Updates:</strong> Signed firmware updates with rollback capability, automatic patching for critical vulnerabilities</li>
                            <li><strong>Data Protection:</strong> Encrypted data transmission from device to platform, no storage of PHI on device</li>
                            <li><strong>Logical Access:</strong> Disable unused ports/services, change default passwords, principle of least privilege</li>
                        </ul>
                    </div>
                </div>

            </div>
        </div>
    </section>

    <!-- Patient Digital Twin -->
    <section class="u-pad-80px-0 frameworks" id="digital-twin" >
        <div class="container">
            <div class="framework-item">
                <h2 class="u-fon-2-5rem-col-neutral-mar-30px"><i class="fas fa-user-md"></i> Patient Digital Twin Architecture</h2>

                <p class="u-col-neutral-fon-1-1rem-lin-mar-40px">
                    The <strong>Patient Digital Twin</strong> is a probabilistic computational model that mirrors the real patient's health state and continuously updates as new data arrives. It's the core innovation enabling personalized predictions and interventions.
                </p>

                <!-- Conceptual Foundation -->
                <div class="u-mar-50px">
                    <h3 class="u-col-primary-fon-2rem-mar-25px"><i class="fas fa-lightbulb"></i> Conceptual Foundation</h3>

                    <div class="u-bac-rgba-0-2-pad-25px-bor-mar-25px">
                        <h4 class="u-col-neutral-mar-15px">What is a Digital Twin?</h4>
                        <p class="framework-content p">
                            Originally from manufacturing (Boeing uses digital twins of aircraft engines to predict maintenance needs), a digital twin is a virtual replica that simulates the behavior of its physical counterpart. In healthcare, the "physical counterpart" is the patient's body, and the twin predicts disease progression, treatment response, and health risks.
                        </p>
                        <p class="u-col-neutral-lin-mar-15px">
                            <strong>Key Difference vs. Traditional ML:</strong> Most ML models make one-time predictions (e.g., "Will this patient be readmitted?"). A digital twin is <strong>stateful and recursive</strong>—it maintains a probabilistic belief about patient health that updates continuously as new observations arrive (lab results, medication changes, self-reported symptoms).
                        </p>
                    </div>

                    <div class="u-bac-rgba-0-0-pad-25px-bor-mar-25px">
                        <h4 class="u-col-accent-c-mar-15px"><i class="fas fa-flask"></i> IHEP's Digital Twin Components</h4>
                        <div class="u-dis-grid-gri-gap-4">
                            <div>
                                <strong class="contact-item a">1. State Variables</strong>
                                <ul class="card-features u-mar-10px-fon-0-9rem">
                                    <li>CD4 count (immune health)</li>
                                    <li>Viral load (HIV replication)</li>
                                    <li>Medication adherence rate</li>
                                    <li>Comorbidities (diabetes, hypertension)</li>
                                    <li>Social determinants (housing stability, food security)</li>
                                </ul>
                            </div>
                            <div>
                                <strong class="contact-item a">2. Probabilistic Model</strong>
                                <ul class="card-features u-mar-10px-fon-0-9rem">
                                    <li>Bayesian network encoding causal relationships</li>
                                    <li>E.g., Poor adherence → higher viral load → lower CD4 count → increased opportunistic infections</li>
                                    <li>Uncertainty quantification (95% credible intervals)</li>
                                </ul>
                            </div>
                            <div>
                                <strong class="contact-item a">3. Update Mechanism</strong>
                                <ul class="card-features u-mar-10px-fon-0-9rem">
                                    <li>Bayesian inference: posterior = prior × likelihood</li>
                                    <li>New lab result arrives → update beliefs about current state</li>
                                    <li>Recursive loop: today's posterior = tomorrow's prior</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Mathematical Framework -->
                <div class="u-mar-50px">
                    <h3 class="u-col-primary-fon-2rem-mar-25px"><i class="fas fa-calculator"></i> Mathematical Framework: Recursive Bayesian Update</h3>

                    <div class="equation-block u-mar-30px-0">
                        <h4 class="u-col-primary-mar-15px">Core Update Equation</h4>
                        <p>At each time step $t$, update the patient state estimate $\theta_t$ given new observation $\mathcal{D}_{t+1}$:</p>
                        $$P(\theta_{t+1}|\mathcal{D}_{1:t+1}) \propto P(\mathcal{D}_{t+1}|\theta_{t+1}) \cdot P(\theta_{t+1}|\mathcal{D}_{1:t})$$
                        <p class="u-mar-20px"><strong>Where:</strong></p>
                        <ul class="u-mar-10px-pad-20px-col-neutral-">
                            <li>$\theta_{t+1}$ = Patient state variables at time $t+1$ (CD4, viral load, adherence, etc.)</li>
                            <li>$\mathcal{D}_{1:t+1}$ = All observations from time 1 through $t+1$ (cumulative clinical data)</li>
                            <li>$P(\mathcal{D}_{t+1}|\theta_{t+1})$ = <strong>Likelihood:</strong> How probable is the new observation given current state?</li>
                            <li>$P(\theta_{t+1}|\mathcal{D}_{1:t})$ = <strong>Prior:</strong> What did we believe about the state before seeing new data?</li>
                            <li>$P(\theta_{t+1}|\mathcal{D}_{1:t+1})$ = <strong>Posterior:</strong> Updated belief after incorporating new observation</li>
                        </ul>
                    </div>

                    <div class="u-bac-rgba-0-2-pad-25px-bor-mar-30px-0">
                        <h4 class="u-col-neutral-mar-15px"><i class="fas fa-lightbulb"></i> Intuition: Learning from Every Data Point</h4>
                        <p class="framework-content p">
                            Imagine a patient with previously stable viral load suddenly shows a spike in their latest lab result. The digital twin asks:
                        </p>
                        <ul class="card-features u-mar-15px">
                            <li><strong>Prior belief:</strong> "This patient has been adherent and stable for 6 months" → low probability of viral rebound</li>
                            <li><strong>New observation:</strong> Viral load jumped from <50 copies/mL to 1,200 copies/mL</li>
                            <li><strong>Likelihood:</strong> "If patient is truly adherent, this spike has only 5% probability (maybe lab error). If patient became non-adherent, spike has 70% probability."</li>
                            <li><strong>Posterior update:</strong> Increase probability of non-adherence, flag patient for adherence counseling intervention</li>
                        </ul>
                        <p class="u-col-neutral-lin-mar-15px">
                            The key is that the twin doesn't blindly trust the new data (could be lab error) or ignore it (could be real crisis). It <strong>rationally integrates</strong> the new signal with historical context.
                        </p>
                    </div>

                    <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0-2">
                        <h4 class="u-col-accent-c-mar-15px"><i class="fas fa-code"></i> Implementation: Particle Filter for Nonlinear Dynamics</h4>
                        <p class="u-col-neutral-lin-mar-15px-2">
                            HIV disease dynamics are highly nonlinear (viral replication, immune response, drug resistance mutations). Standard Kalman filters assume linear Gaussian dynamics; we use a <strong>particle filter (Sequential Monte Carlo)</strong>:
                        </p>
                        <ol class="u-col-neutral-pad-20px-lin">
                            <li><strong>Initialize:</strong> Sample $N=1000$ particles (each is a plausible patient state) from prior distribution</li>
                            <li><strong>Predict:</strong> For each particle, simulate forward one time step using disease dynamics model (e.g., viral kinetics equations)</li>
                            <li><strong>Update:</strong> Weight each particle by likelihood of observed data given that particle's state</li>
                            <li><strong>Resample:</strong> Keep high-weight particles, discard low-weight ones. This concentrates computational effort on plausible hypotheses.</li>
                            <li><strong>Estimate:</strong> Posterior distribution = weighted ensemble of particles. Median = point estimate, spread = uncertainty.</li>
                        </ol>
                        <p class="u-col-neutral-lin-mar-15px">
                            This allows us to handle arbitrary nonlinearities, multimodal posteriors (e.g., "patient is either fully adherent or completely non-adherent, but not in between"), and uncertainty quantification critical for clinical decision support.
                        </p>
                    </div>
                </div>

                <!-- Predictive Capabilities -->
                <div class="u-mar-50px">
                    <h3 class="u-col-primary-fon-2rem-mar-25px"><i class="fas fa-crystal-ball"></i> Predictive Capabilities & Clinical Applications</h3>

                    <div class="u-dis-grid-gri-gap-5">
                        <div class="u-bac-rgba-0-2-bor-pad-20px-bor">
                            <h5 class="u-col-primary-mar-10px">Viral Rebound Prediction</h5>
                            <p class="u-col-neutral-fon-0-95re">
                                <strong>Goal:</strong> Predict viral load rebound 3-6 months in advance, enabling proactive intervention before clinical deterioration.
                            </p>
                            <p class="u-col-neutral-fon-0-9rem-mar-10px">
                                <strong>Inputs:</strong> Medication refill patterns (proxy for adherence), historical viral load trajectory, CD4 trends, drug resistance mutations (if available)
                            </p>
                            <p class="u-col-accent-c-fon-0-9rem-mar-10px">
                                <strong>Performance:</strong> AUC-ROC 0.88, sensitivity 82% at 75% specificity
                            </p>
                        </div>

                        <div class="u-bac-rgba-123-bor-pad-20px-bor">
                            <h5 class="u-col-primary-mar-10px-2">Adherence Forecasting</h5>
                            <p class="u-col-neutral-fon-0-95re">
                                <strong>Goal:</strong> Identify patients at high risk of treatment discontinuation within next 30 days.
                            </p>
                            <p class="u-col-neutral-fon-0-9rem-mar-10px">
                                <strong>Inputs:</strong> Missed appointments, unreturned care coordinator calls, pharmacy refill gaps, social determinants (housing instability, substance use)
                            </p>
                            <p class="u-col-accent-c-fon-0-9rem-mar-10px">
                                <strong>Performance:</strong> AUC-ROC 0.91, identifies 75% of future non-adherers with 20% false positive rate
                            </p>
                        </div>

                        <div class="u-bac-rgba-255-bor-pad-20px-bor">
                            <h5 class="u-col-accent-m-mar-10px">Opportunistic Infection Risk</h5>
                            <p class="u-col-neutral-fon-0-95re">
                                <strong>Goal:</strong> Stratify patients by risk of opportunistic infections (OIs) requiring hospitalization.
                            </p>
                            <p class="u-col-neutral-fon-0-9rem-mar-10px">
                                <strong>Inputs:</strong> CD4 count trajectory, prophylaxis medication adherence, comorbidities (diabetes, COPD), social risk factors
                            </p>
                            <p class="u-col-accent-c-fon-0-9rem-mar-10px">
                                <strong>Performance:</strong> C-statistic 0.85 for 6-month OI prediction
                            </p>
                        </div>
                    </div>
                </div>

            </div>
        </div>
    </section>

    <!-- 10-Year Roadmap to Cure -->
    <section class="u-pad-80px-0-bac-linear-g-2 frameworks" id="cure-milestones" >
        <div class="container">
            <div class="framework-item">
                <h2 class="u-fon-2-5rem-col-neutral-mar-30px"><i class="fas fa-map-signs"></i> 10-Year Roadmap to HIV/AIDS Functional Cure</h2>

                <p class="u-col-neutral-fon-1-1rem-lin-mar-40px">
                    While optimizing existing care delivers immediate value, IHEP's <strong>long-term moonshot goal</strong> is achieving a functional cure for HIV: sustained viral suppression without ongoing antiretroviral therapy (ART). This requires AI-driven therapeutic discovery targeting the viral reservoir.
                </p>

                <div class="u-bac-rgba-255-bor-2px-soli-pad-30px-bor-mar-50p">
                    <h3 class="u-col-accent-m-mar-20px"><i class="fas fa-question-circle"></i> Why a Cure is Needed (Despite Effective ART)</h3>
                    <p class="u-col-neutral-lin-mar-15px-2">
                        Modern ART reduces HIV to undetectable levels, but patients must take daily medication for life. The virus persists in <strong>latent reservoirs</strong> (resting CD4+ T cells, tissue macrophages) that ART cannot eliminate. If ART stops, viral rebound occurs within 2-4 weeks in 99% of patients.
                    </p>
                    <ul class="card-features">
                        <li><strong>Lifetime ART Burden:</strong> Cumulative cost $400K-600K per patient, daily medication adherence challenge, long-term toxicity (kidney damage, bone loss)</li>
                        <li><strong>Stigma & Quality of Life:</strong> Daily reminder of disease status, disclosure challenges in relationships/employment</li>
                        <li><strong>Global Access:</strong> ART requires healthcare infrastructure unavailable in many low-resource settings</li>
                        <li><strong>The Cure Vision:</strong> One-time or intermittent treatment eliminates viral reservoir → sustained remission without ART</li>
                    </ul>
                </div>

                <!-- Phased Roadmap -->
                <div class="u-mar-50px">
                    <h3 class="u-col-primary-fon-2rem-mar-25px"><i class="fas fa-road"></i> Phased Development Roadmap</h3>

                    <div class="u-dis-grid-gri-gap-6">
                        <!-- Years 0-2 -->
                        <div class="u-bac-rgba-0-2-bor-pad-25px-bor">
                            <h4 class="u-col-primary-mar-15px"><i class="fas fa-play"></i> Years 0-2: Foundation & MVP</h4>
                            <p class="u-col-neutral-fon-1-05re-mar-15px">
                                <strong>Focus:</strong> Build core platform, deploy MVP with 350 patients, establish baseline metrics
                            </p>
                            <ul class="card-features">
                                <li><strong>SBIR Phase I ($275K):</strong> Feasibility study, prototype digital twin, NIST AI RMF compliance audit</li>
                                <li><strong>SBIR Phase II ($2M):</strong> Full platform development, clinical pilot at 2-3 FQHCs</li>
                                <li><strong>Clinical Milestones:</strong> Achieve ≥95% viral suppression in pilot cohort, demonstrate 30% cost reduction vs standard care</li>
                                <li><strong>Data Collection:</strong> Accumulate 350 patient-years of longitudinal data (viral load, CD4, adherence, outcomes)</li>
                                <li><strong>Regulatory:</strong> Submit FDA Pre-Submission for Software as Medical Device (SaMD) classification</li>
                            </ul>
                        </div>

                        <!-- Years 3-5 -->
                        <div class="u-bac-rgba-123-bor-pad-25px-bor">
                            <h4 class="u-col-primary-mar-15px-2"><i class="fas fa-chart-line"></i> Years 3-5: Scale-Up & Discovery Initiation</h4>
                            <p class="u-col-neutral-fon-1-05re-mar-15px">
                                <strong>Focus:</strong> Scale to 5,000+ patients, initiate Generative Bio-AI therapeutic discovery
                            </p>
                            <ul class="card-features">
                                <li><strong>SBIR Phase III ($10M+):</strong> Commercialization support, multi-site deployment (20+ clinics)</li>
                                <li><strong>Platform Expansion:</strong> 5,000 patient capacity, 50+ care coordinators trained, EHR integration (Epic, Cerner)</li>
                                <li><strong>Bio-AI Pipeline Launch:</strong> Train generative models (VAEs, diffusion models) on molecular databases to design latency-reversing agents (LRAs)</li>
                                <li><strong>Target Validation:</strong> In silico screening of 10,000+ candidate molecules targeting known latency mechanisms (histone deacetylases, NF-κB pathway)</li>
                                <li><strong>Academic Partnerships:</strong> Collaborate with UCSF, Johns Hopkins, Wistar Institute for in vitro validation of top candidates</li>
                            </ul>
                        </div>

                        <!-- Years 6-8 -->
                        <div class="u-bac-rgba-255-bor-pad-25px-bor">
                            <h4 class="u-col-accent-m-mar-15px"><i class="fas fa-flask"></i> Years 6-8: Preclinical & Phase I Trials</h4>
                            <p class="u-col-neutral-fon-1-05re-mar-15px">
                                <strong>Focus:</strong> Translate AI-discovered compounds into IND-ready therapeutics
                            </p>
                            <ul class="card-features">
                                <li><strong>Lead Optimization:</strong> Top 10 AI-discovered LRAs enter medicinal chemistry optimization for ADMET properties (absorption, distribution, metabolism, excretion, toxicity)</li>
                                <li><strong>Preclinical Studies:</strong> Humanized mouse models (NSG mice engrafted with human immune cells + HIV) to test in vivo efficacy</li>
                                <li><strong>IND Submission:</strong> Investigational New Drug application to FDA for lead compound</li>
                                <li><strong>Phase I Trial:</strong> Safety & dose-finding study in 20-40 HIV+ patients on stable ART. Primary endpoint: incidence of adverse events. Secondary: change in viral reservoir size (measured via quantitative viral outgrowth assay)</li>
                                <li><strong>Funding:</strong> NIH R01 grants, pharma partnerships (licensing agreements with option to acquire)</li>
                            </ul>
                        </div>

                        <!-- Years 9-10 -->
                        <div class="u-bac-rgba-0-2-bor-pad-25px-bor-2">
                            <h4 class="u-col-accent-c-mar-15px"><i class="fas fa-trophy"></i> Years 9-10: Phase II Trials & Functional Cure Demonstration</h4>
                            <p class="u-col-neutral-fon-1-05re-mar-15px">
                                <strong>Focus:</strong> Efficacy trials for functional cure in combination therapy
                            </p>
                            <ul class="card-features">
                                <li><strong>Combination Therapy Design:</strong> AI-discovered LRA + immune checkpoint inhibitor (e.g., anti-PD-1) to eliminate reactivated reservoir cells ("shock and kill" strategy)</li>
                                <li><strong>Phase II Trial:</strong> Randomized controlled trial in 100-200 patients. Intervention: LRA + immune therapy for 12 weeks, then monitored analytical treatment interruption (ATI) for 24 weeks</li>
                                <li><strong>Primary Endpoint:</strong> % of patients maintaining undetectable viral load for ≥24 weeks after stopping ART (defines functional cure)</li>
                                <li><strong>Success Criteria:</strong> ≥30% functional cure rate (vs <1% spontaneous remission rate)</li>
                                <li><strong>Breakthrough Therapy Designation:</strong> Apply for FDA BTD if Phase IIa shows promising signal, enabling accelerated development</li>
                                <li><strong>Commercial Milestone:</strong> Partner with major pharma for Phase III trials & global commercialization. Expected licensing deal: $100M upfront + milestones + royalties</li>
                            </ul>
                        </div>
                    </div>
                </div>

            </div>
        </div>
    </section>

    <!-- Call to Action -->
    <section class="u-pad-80px-0-bac-linear-g-3">
        <div class="container metric">
            <h2 class="u-fon-2-5rem-col-neutral-mar-20px">Join the Mission to End HIV/AIDS</h2>
            <p class="u-fon-1-2rem-col-neutral-max-mar-0-auto">
                Whether you're a clinical partner, investor, or academic researcher, there's a role for you in making IHEP's vision a reality.
            </p>
            <div class="u-dis-flex-gap-jus-fle">
                <a class="u-fon-1-1rem-pad-15px-4 btn btn-primary" href="index.html#contact" >
                    <i class="fas fa-envelope"></i> Request Full IHEP Framework Documentation
                </a>
                <a class="u-fon-1-1rem-pad-15px-4 btn btn-secondary" href="projects_portfolio.html" >
                    <i class="fas fa-arrow-left"></i> Back to Projects Portfolio
                </a>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="site-footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-section">
                    <h4>Jason Jarmacz</h4>
                    <p>NeuroProgressive AI Evolution Strategist</p>
                    <p class="footer-tagline">"Advancing with strict moral compass, letting discoveries define ambitions."</p>
                </div>
                <div class="footer-section">
                    <h4>Projects</h4>
                    <ul>
                        <li><a href="neuroprogressive-ai.html">NeuroProgressive AI Platform</a></li>
                        <li><a href="ihep.html">IHEP Framework</a></li>
                        <li><a href="projects_portfolio.html">All Projects</a></li>
                    </ul>
                </div>
                <div class="footer-section">
                    <h4>Technical Docs</h4>
                    <ul>
                        <li><a href="#nist-compliance">NIST Compliance</a></li>
                        <li><a href="#digital-twin">Patient Digital Twin</a></li>
                        <li><a href="#cure-milestones">Cure Roadmap</a></li>
                    </ul>
                </div>
                <div class="footer-section">
                    <h4>Connect</h4>
                    <ul>
                        <li><a href="mailto:jayjarmacz@gmail.com">jayjarmacz@gmail.com</a></li>
                        <li><a href="tel:+19175668112">(917) 566-8112</a></li>
                        <li><a href="https://linkedin.com/in/omniunum" target="_blank">LinkedIn</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2025 Jason Jarmacz. All rights reserved.</p>
                <p>IHEP Framework - NIST AI RMF 1.0 Compliant</p>
            </div>
        </div>
    </footer>

    <!-- Scripts -->
    <script>
    // MathJax Configuration
    window.MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']]
        },
        svg: {
            fontCache: 'global'
        },
        chtml: {
            mtextInheritFont: true
        },
        startup: {
            ready: () => {
                MathJax.startup.defaultReady();
                MathJax.startup.promise.then(() => {
                    const style = document.createElement('style');
                    style.textContent = `
                        mjx-container, mjx-container * {
                            color: #00f5ff !important;
                        }
                        mjx-math {
                            color: #00f5ff !important;
                        }
                    `;
                    document.head.appendChild(style);
                });
            }
        }
    };
    </script>
        <script src="https://code.jquery.com/jquery-3.6.0.slim.min.js" integrity="sha256-u7e5khyithlIdTpu22PHhENmPcRdFiHRjhAuHcs05RI=" crossorigin="anonymous"></script>
        <script src="js/main.js"></script>
</body>
</html>
